Nasogastric Tube Market Size & Growth Forecast 2027–2036, By Segments (End-Use, Patient Type, Indication, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to content
Market Size and Growth Outlook
Nasogastric Tube Market size was valued at USD 602.46 million in 2026 and is anticipated to grow at a 5.04% CAGR from 2027 to 2036, attaining USD 985.09 million by 2036. The industry revenue for 2027 is assessed at USD 628 million.
Get more details on this report
Request Free Sample ReportNasogastric Tube Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 39.86% of the market in 2026, supported by mature hospital infrastructure, high procedural volumes, standardized care pathways, and widespread clinical use across acute and long-term care.
- Asia Pacific is projected to grow at a 6.1% CAGR due to improving hospital access, rising treatment volumes, expanding healthcare capacity, and broader adoption of enteral feeding practices.
Segment Momentum
- Hospitals & Nursing Homes accounted for a 62.69% share in 2026 because they routinely manage enteral feeding, medication delivery, and gastric decompression under continuous clinical supervision.
- Geriatric is the fastest-growing patient segment as older adults increasingly require assisted feeding due to swallowing difficulties, frailty, and age-related conditions that limit oral nutrition.
Market Expansion Drivers
- Rising prevalence of chronic diseases increasing demand for enteral feeding support devices.
- Increasing ICU admissions and hospital malnutrition cases driving nasogastric tube utilization.
- Growing preference for enteral nutrition over parenteral feeding in clinical care settings.
Leading Market Participants
- Major players in the nasogastric tube market include Becton, Dickinson and Company (United States), Medtronic plc (Ireland), Cardinal Health, Inc. (United States), Vygon SAS (France), Poly Medicure Limited (India), Angiplast Pvt. Ltd. (India), Baihe Medical Technology Co., Ltd. (China), QMD (United Kingdom), Securmed S.p.A. (Italy).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 602.46 million
- 2027 Estimated Market Size: USD 628 million.
- Projected Market Size: USD 985.09 million by 2036
- Growth Forecast: 5.04% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals & Nursing Homes (End-Use) | Adult (Patient Type) | Dysphagia (Indication) | Small-bore Feeding Tubes (Type)
- Emerging Opportunity Segment: Home Care (End-Use) | Geriatric (Patient Type) | Stomach Cancer (Indication) | Small-bore Feeding Tubes (Type)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic diseases increasing demand for enteral feeding support devices
The growing prevalence of chronic diseases is supporting nasogastric tube market growth as more patients require nutritional support when normal oral intake is inadequate or impractical. The need to maintain appropriate nutrition during the management of chronic conditions increases reliance on enteral feeding devices, supporting their use across clinical care settings where ongoing nutritional assistance is required.
Increasing ICU admissions and hospital malnutrition cases driving nasogastric tube utilization
Higher ICU admissions and the presence of malnutrition among hospitalized patients are increasing demand for nasogastric tubes, particularly where patients require assisted nutritional delivery. In critical care environments, these devices provide a practical route for enteral feeding when patients cannot meet nutritional needs independently, while hospital malnutrition management further supports their utilization as part of patient care.
Growing preference for enteral nutrition over parenteral feeding in clinical care settings
A growing clinical preference for enteral nutrition is supporting the nasogastric tube market as healthcare providers increasingly use the gastrointestinal route for nutritional support when appropriate. This preference encourages the use of nasogastric tubes as a practical means of delivering nutrition to patients who cannot consume sufficient food orally, reinforcing their role in hospital-based nutritional management.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Hospital & Clinical Adoption of Nasogastric Tubes | 2.00% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Fast |
| Technological Improvements & Safety Features | 1.80% | Medium term (2–5 yrs) | Europe, North America (spillover: Asia Pacific) | Low | Moderate |
| Regulatory Medical Device Approvals | 1.60% | Long term (5+ yrs) | North America, Europe (spillover: MEA) | High | Moderate |
| Rising prevalence of chronic diseases increasing demand for enteral feeding support devices | 2.30% | High | North America, Europe | High | Near Term |
| Increasing ICU admissions and hospital malnutrition cases driving nasogastric tube utilization | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Growing preference for enteral nutrition over parenteral feeding in clinical care settings | 1.60% | High | Europe, North America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The nasogastric tube market was led by North America, which accounted for 39.86% of the market in 2026, supported by advanced hospital infrastructure, established clinical protocols, and widespread use of enteral feeding and gastric decompression procedures. Demand is reinforced by the region's sophisticated critical care and surgical environments, where nasogastric tubes remain important for patients requiring nutritional support or gastrointestinal management. Continued attention to patient safety, infection prevention, product quality, and minimally invasive care is also encouraging healthcare facilities to adopt reliable and clinically optimized tube systems.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, benefiting from expanding healthcare infrastructure, increasing access to hospital-based treatment, and rising demand for enteral nutrition and critical care services. Improvements in medical facilities across emerging economies are broadening the availability of specialized gastrointestinal and nutritional support procedures. An aging population, increasing prevalence of chronic conditions, and greater awareness of hospital-acquired complications are contributing to demand for dependable medical devices. At the same time, domestic manufacturing capabilities and expanding healthcare investment are improving product accessibility and supporting broader adoption across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
Germany 🇩🇪
Precision Care StandardsGermany prioritizes high-quality nasogastric tubes that comply with stringent clinical standards and infection control requirements. Medical facilities in Germany continue investing in reliable devices that improve patient comfort and procedural efficiency across acute care settings.
France 🇫🇷
Critical Care SupportFrance is strengthening the use of nasogastric tubes across intensive care and postoperative treatment pathways. Clinical institutions in France prioritize dependable devices that support enteral feeding while maintaining high standards for patient safety and hygiene.
Italy 🇮🇹
Healthcare Procurement FocusItaly emphasizes reliable nasogastric tube procurement that balances clinical performance with healthcare efficiency. Hospitals in Italy are adopting products that simplify handling, improve patient comfort, and support consistent nutritional management across healthcare facilities.
Japan 🇯🇵
Patient Comfort PriorityJapan focuses on minimally invasive nasogastric tube designs that enhance patient comfort during extended nutritional support. Hospitals in Japan are adopting advanced materials and improved tube configurations to reduce irritation and facilitate safer clinical outcomes.
South Korea 🇰🇷
Hospital Technology AdoptionSouth Korea supports wider adoption of technologically enhanced nasogastric tubes within modern hospital environments. Healthcare providers in South Korea are emphasizing efficient placement techniques and product quality to improve treatment consistency and patient care.
United States 🇺🇸
Clinical Innovation FocusThe U.S. nasogastric tube market emphasizes patient safety, improved placement accuracy, and material innovation. Healthcare providers in the U.S. increasingly adopt advanced tube designs that reduce complications while supporting efficient nutritional and therapeutic care.
Nasogastric Tube Market Share (%), by End-Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-Use Segment Analysis: Hospitals & Nursing Homes (Largest Segment) vs Home Care (Fastest-Growing Segment)
Hospitals & nursing homes dominated the nasogastric tube market, accounting for a 62.69% share in 2026. The segment's leading position is supported by the extensive use of nasogastric tubes for enteral feeding, medication administration, gastric decompression, and other clinical procedures requiring controlled access to the gastrointestinal tract. Hospitals and nursing homes manage a broad range of patients requiring nutritional and therapeutic support, creating consistent demand for these devices. The need for efficient bedside care, particularly among patients who cannot consume food orally, further sustains utilization across institutional healthcare settings.
Home care is the fastest-growing end-use segment as healthcare delivery increasingly shifts toward outpatient and home-based treatment. Nasogastric feeding can allow patients requiring extended nutritional support to receive care outside conventional healthcare facilities, reducing the need for prolonged institutional stays when clinically appropriate. Improvements in caregiver training, home healthcare services, and patient monitoring are supporting greater adoption of enteral care in residential settings. The broader movement toward convenient, patient-centered healthcare is therefore creating additional demand for nasogastric tubes in home care.
Patient Type Segment Analysis: Adult (Largest Segment) vs Geriatric (Fastest-Growing Segment)
The adult segment held a 39.11% share in 2026, making it the largest patient type category in the nasogastric tube market. Demand is supported by the broad use of nasogastric tubes among adults requiring temporary or extended enteral nutrition, medication delivery, or gastric decompression. These devices are commonly incorporated into treatment pathways for patients experiencing conditions that limit normal oral intake or require gastrointestinal management. The wide range of adult clinical indications provides a substantial base for continued nasogastric tube utilization across healthcare facilities.
Geriatric is the fastest-growing patient type segment, driven by increasing nutritional and clinical care requirements among older patients. Age-related health challenges, swallowing difficulties, reduced appetite, and prolonged recovery from illness can increase the need for enteral nutritional support. As healthcare systems place greater emphasis on managing older patients across hospitals, long-term care facilities, and home settings, the need for practical enteral feeding solutions is increasing. This trend is strengthening demand for nasogastric tubes designed for geriatric patient care.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-Use | Hospitals & Nursing Homes, Home Care | Hospitals & Nursing Homes | Home Care |
| Patient Type | Adult, Pediatric, Geriatric | Adult | Geriatric |
| Indication | Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, Others | Dysphagia | Stomach Cancer |
| Type | Small-bore Feeding Tubes, Large-bore Feeding Tubes | Small-bore Feeding Tubes | Small-bore Feeding Tubes |
Competitive Landscape and Market Positioning
Prominent players in the nasogastric tube market:
1. Becton Dickinson and Company (United States)
2. Medtronic plc (Ireland)
3. Cardinal Health Inc. (United States)
4. Vygon SAS (France)
5. Poly Medicure Limited (India)
6. Angiplast Pvt. Ltd. (India)
7. Baihe Medical Technology Co. Ltd. (China)
8. QMD (United Kingdom)
9. Securmed S.p.A. (Italy)
The nasogastric tube market is progressing through continuous improvements in patient safety and clinical usability. In the nasogastric tube market, design enhancements are focused on improving comfort and reducing procedural complications. Innovation efforts are centered around material refinement and functional efficiency. Growing clinical demand for safer enteral feeding solutions is also driving iterative product upgrades.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Cardinal Health Inc. (United States) | |||||||
| Vygon SAS (France) | |||||||
| Poly Medicure Limited (India) | |||||||
| Angiplast Pvt. Ltd. (India) | |||||||
| Baihe Medical Technology Co. Ltd. (China) | |||||||
| QMD (United Kingdom) | |||||||
| Securmed S.p.A. (Italy). |
Industry Development / News
| Company Name | Date | Key Development |
|---|---|---|
| Enteral Access Technologies | Nov-25 | Enteral Access Technologies secured £500,000 in funding led by the British Design Fund. The capital is earmarked for international expansion and the further commercialization of its proprietary patient safety devices for enteral access, strengthening the company's competitive position within the specialized nasogastric and feeding device market segment. |
| Leeds Teaching Hospitals | Jan-25 | Leeds Teaching Hospitals implemented a radiographer-led verification pathway for nasogastric tube positioning. This clinical workflow innovation serves to enhance the accuracy and reliability of tube placement verification, establishing a more robust safety standard for enteral feeding practices within healthcare delivery systems. |
| Dale Medical | Jul-24 | Dale Medical introduced the UltraGrip nasogastric tube holder, expanding its portfolio of enteral access support solutions. The device is engineered to improve tube stability and patient comfort, addressing critical clinical needs for effective securement mechanisms in hospital and long-term care environments. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Nasogastric Tube Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Material | Polyurethane, Silicone, PVC, Other Materials |
| Placement Method | Nasal Placement, Oral Placement |
| Duration of Use | Short-Term Use, Intermediate-Term Use, Long-Term Use |
Nasogastric Tube Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Home Healthcare Adoption Opportunity Analysis |
|
| Hospital Procurement Decision Study |
|
| Alternative Feeding Technology Impact Study |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the market valuation of nasogastric tube?
What is the projected value of the nasogastric tube industry by 2036?
How is the rising prevalence of chronic diseases influencing demand in the nasogastric tube market?
Why is the shift toward enteral nutrition strengthening nasogastric tube adoption in clinical care settings?
Why are hospitals and nursing homes the largest end users in the nasogastric tube market?
Which patient type is growing the fastest in the nasogastric tube market?
Why does North America dominate the nasogastric tube market?
What factors are driving nasogastric tube market growth in Asia Pacific?
Which companies dominate the nasogastric tube landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook